Search

everythinglearnresearchcommunity

for

Search:↓

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Hair follicle organoids can help study hair biology and disorders but need improvements for wider use.

Certain medications, especially nervous system drugs, can cause insomnia, with risks varying by age and gender.

The new microneedle system improves hair growth in alopecia treatment.

The hydrogel dressing improves wound healing, offers long-lasting antibacterial effects, and enhances patient comfort.

Exosomes can improve skin treatments with fewer side effects.

New treatments for hair loss show promise with advanced therapies and better targeting.

Topical minoxidil can cause severe liver failure.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

A 5% minoxidil spray could effectively treat male baldness with fewer side effects and better patient comfort.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Innovative methods are reducing animal testing and improving biomedical research.

One Ashwagandha extract may help protect cells with its antioxidant properties, while another could promote hair growth.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

3D-oxy exosomes may significantly boost hair growth, offering new treatment options for hair loss.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Hair follicle culture helps study hair growth but has limitations in modeling the full hair cycle.

Psoriasis treatments range from topical creams to systemic medications with serious side effects, and while treatments can manage symptoms, there is no cure.

Microneedling can effectively improve hair growth and thickness in men with hair loss.

Smart microneedles can deliver drugs painlessly and accurately for diseases like diabetes and tumors.

A new wearable system improves wound healing by monitoring infections and delivering precise treatment.

Solid lipid nanoparticles are promising for safe and effective drug delivery but need more research for clinical use.

Zebrafish helped find new ways to prevent drug-induced hair cell death and potential treatments for hearing loss.

Peptide drugs now target hard-to-reach proteins more effectively and specifically.

Inorganic-based biomaterials can quickly stop bleeding and help wounds heal, but they may cause issues like sharp ion release and pH changes.

Semifluorinated alkanes are promising for delivering drugs in various medical applications.